NSW Cannabis Medicines Advisory Service

The NSW Government-funded NSW Cannabis Medicines Advisory Service (CMAS) provides free clinical guidance and advice to NSW medical practitioners considering prescribing a cannabis medicine for their patient.

CMAS can provide:

  • Information about cannabis medicines (e.g. formulations, dosing, potential drug interactions).
  • Advice tailored to patient-specific clinical context.
  • Current scientific evidence, to support applications for authority to prescribe.
  • Guidance and tools for monitoring potential therapeutic and adverse effects.
  • Information on open clinical trials using cannabis medicines.

CMAS was launched in January 2018 and is headquartered in Newcastle within Hunter New England Health. This ensures access to expert clinical advice for both metropolitan and regional practitioners, including those based in rural and remote areas. It is staffed by senior pharmacists, a clinical pharmacologist and an administration officer.

Who can contact CMAS 

Any medical practitioner in NSW can contact CMAS, as well as other health professionals and services, including pharmacists, nurses, pain clinics and clinical trials.

CMAS provides support for:

  • NSW heath professionals; and
  • NSW health professionals who are treating a patient in a cross-border area of NSW; and 
  • Health professionals in a state or territory outside of NSW who are treating a patient residing in NSW. 

Contact details

Available 9.00 am – 5.00 pm, Monday to Friday
Phone: 02 4923 6200
Email: HNELHD-CMAS@health.nsw.gov.au

COVID-19 update for health professionals: Due to COVID-19, NSW registered doctors and health professionals are asked to email CMAS as the first point of contact. If a call back is required, please email your preferred contact number and call back time. The CMAS inbox is being monitored during business hours and staff will endeavour to call enquirers back, where requested, within one business day.